American Journal of Epidemiology Vol. 115, No. 2: 243-254
Copyright © 1982 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
MORTALITY IN WOMEN TREATED FOR HYPERTHYROIDISM
1Environmental Epidemiology Branch, National Cancer Institute Rm. 3C-07, Landow Bldg., Bethesda, MD 20205
2Department of Internal Medicine, Division of Endocrinology/Metabolism and Internal Medicine (WMcC), and Department of Medical Statistics and Epidemiology (LTK) Mayo Clinic, Rochester, MN
3Department of Epidemiology, Johns Hopkins School of Hygiene and Public Health Baltimore, MD.
Send reprint requests to Dr. Hoffman at this address.
To evaluate the late effects of exposure to radioiodine (131I), a retrospective cohort study was conducted of women treated for hyperthyroidism at the Mayo Clinic, Rochester, Minnesota, from 1946 through 1964. Cause of death was determined in 1005 women treated with 131I and in 2141 women surgically treated. No Increased risk of total mortality was observed for the 131I-treated women (relative risk = 1.0). There were no increased risks for the major causes of mortality (cancer, cardiovascular-renal disease or cerebrovascular lesions) in the 131I-treated women; in addition, there were no increased risks for site-specific cancer mortality. Several hypotheses are presented to suggest reasons for the lack of an association between 131I exposure and increased cancer mortality.
cancer; hyperthyroidism; mortality; radiation effects
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Haentjens, A. Van Meerhaeghe, K. Poppe, and B. Velkeniers Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies Eur. J. Endocrinol., September 1, 2008; 159(3): 329 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Metso, P. Jaatinen, H. Huhtala, A. Auvinen, H. Oksala, and J. Salmi Increased Cardiovascular and Cancer Mortality after Radioiodine Treatment for Hyperthyroidism J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2190 - 2196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Boelaert and J A Franklyn Thyroid hormone in health and disease J. Endocrinol., October 1, 2005; 187(1): 1 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.C. Cavalher-Machado, W. T. de Lima, A.S. Damazo, V. de Frias Carvalho, M.A. Martins, P.M.R. e Silva, and P. Sannomiya Down-regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin Eur. Respir. J., October 1, 2004; 24(4): 552 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Biagi, R. G. MacKenzie, M. S. Lim, M. Sapp, and N. Berinstein Primary Hodgkin's disease of the CNS in an immunocompetent patient: A case study and review of the literature Neuro-oncol, October 1, 2000; 2(4): 239 - 243. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Nygaard, L. Hegedus, P. Ulriksen, K. G. Nielsen, and J. M. Hansen Radioiodine Therapy for Multinodular Toxic Goiter Arch Intern Med, June 28, 1999; 159(12): 1364 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ron, M. M. Doody, D. V. Becker, A. B. Brill, R. E. Curtis, M. B. Goldman, B. S. H. Harris III, D. A. Hoffman, W. M. McConahey, H. R. Maxon, et al. Cancer Mortality Following Treatment for Adult Hyperthyroidism JAMA, July 22, 1998; 280(4): 347 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.A. Franklyn, P. Maisonneuve, M.C. Sheppard, J. Betteridge, and P. Boyle Mortality after the Treatment of Hyperthyroidism with Radioactive Iodine N. Engl. J. Med., March 12, 1998; 338(11): 712 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Hoffman, W. M. McConahey, L. A. Brinton, and J. F. Fraumeni Jr Breast Cancer in Hypothyroid Women Using Thyroid Supplements JAMA, February 3, 1984; 251(5): 616 - 619. [Abstract] [PDF]
|
|